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The evolution of infrainguinal bypass grafts has jus-
tified an aggressive approach to limb salvage in almost
all patients who are ambulatory with critical lower
extremity ischemia. Bypass grafts to the tibial and infra-
malleolar vessels have become routine, and the results
have been gratifying.1 The results in patients with end-
stage renal disease (ESRD) have been less encourag-
ing. Numerous authors have documented variable
outcomes in patients with ESRD when they are seen
with limb-threatening ischemia.2-10 These studies
have focused on all revascularizations, with a small
minority of the bypass grafts being to the pedal ves-
sels. Although the survival rates for patients with
ESRD are poor in comparison with the rates for age-
matched controls, the mortality rates for patients
undergoing renal replacement therapy (RRT) have
slowly declined over the last decade.11 This decline
has resulted in an elderly and debilitated population
that is seen with more advanced disease that causes
severe limb-threatening ischemia.
This retrospective study was restricted to patients
with ESRD who required pedal bypass grafting for
limb salvage. The preoperative factors were examined
as were the bypass graft patency rates, the limb sal-
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Purpose: Limb-threatening ischemia in patients with end-stage renal disease (ESRD) rep-
resents a challenging clinical problem. Multiple series have shown the inferior limb sal-
vage rate for femoropopliteal or femorotibial bypass grafts in this group. This outcome
study is restricted to those patients with ESRD who require pedal bypass grafts for
attempted limb salvage.
Methods: Between December 1, 1990, and December 31, 1997, 34 patients with ESRD
underwent pedal bypass grafting on 41 limbs. This review explores the patient and
bypass graft outcomes and their relationships to typical risk factors. 
Results: The average age in the study was 64 years (range, 39 to 85 years). Twenty
patients (59%) were men, 31 (91%) had diabetes, 32 (94%) were hypertensive, and 28
(82%) had coronary artery disease, but only 10 patients (29%) were smokers. All the
patients were undergoing dialysis except 2 patients with functioning renal transplants.
All bypass grafting procedures were performed for limb salvage. The follow-up periods
ranged from 1 to 84 months (average, 13.5 months). With life-table analysis, the cumu-
lative assisted primary patency rate was 62% at 1 year and 62% at 2 years. The limb sal-
vage rate was 56% and 50% at 1 and 2 years, respectively. All the patients who were seen
with heel gangrene had early limb loss or died. Seven of the 16 amputations (44%) were
performed despite patent bypass grafts. Ten of the 16 amputations (63%) occurred with-
in 3 months of the surgery. The survival rate was 64% at 1 year and 52% at 2 years. After
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Conclusion: Modest success can be expected with pedal bypass grafts in patients with
ESRD, with most failures occurring in the first 3 months. Limb salvage rates lag behind
graft patency rates because of progressive necrosis despite a hemodynamically function-
ing bypass graft. Heel gangrene is a strong predictor for a negative outcome. Lastly,
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vage rates, and the survival rates. The hemodynamic
parameters of bypass graft function were assessed to
examine the reasons for limb loss. This study further
investigated any predictors that might identify the
patients who are more appropriate for primary ampu-
tation than an aggressive limb-salvage attempt.
METHODS
The hospital and office records were reviewed for
all the patients receiving RRT (dialysis or transplant)
who had undergone bypass grafting procedures to the
pedal vessels at the Western Pennsylvania Hospital
between December 1, 1990, and December 31, 1997.
The background data included: age, gender, hyperten-
sion, diabetes, coronary disease, presenting lesion, and
status of the contralateral limb. The bypass graft data
included: indication, bypass graft date and type, con-
duit type, and bypass graft revisions. The noninvasive
vascular laboratory data included ankle brachial indices
(ABI) and toe pressures (TP) before and after surgery.
The follow-up information included: bypass patency,
number of adjunctive foot procedures, amputation,
ambulatory status, and mortality rates. If the data were
incomplete, the families or the dialysis units were con-
tacted for further information.
Before surgery, the patients were evaluated clin-
ically and with the noninvasive vascular laboratory
with ABI and TP. X-ray films were ordered to
assess osteomyelitis when clinically indicated, but
bone scanning and magnetic resonance imaging
were not routinely used. The obviously infected
lesions were debrided or drained before the bypass
grafting procedure.
Heel gangrene was defined as a full thickness skin
necrosis that measured at least 4 cm in diameter. Dry
gangrene of the heel skin was protected with soft
dressings and protective splints and was only debrid-
ed in the case of infection. After debridement and
bypass grafting, the large defects were treated with a
combination of skin grafts, muscle rotation flaps,
and free tissue transfer.
During evaluation, all the patients underwent
digital subtraction angiography with specific atten-
tion to the pedal circulation. All the patients had
severe tibial occlusive disease with reconstitution of
1 or more pedal vessels. If the angiogram revealed
tibial vessels that provided a direct flow to the foot,
these outflow vessels were used preferentially. These
patients were not included in this study. The angio-
graphic patterns of tibial occlusive disease and the
pedal circulation are the subject of a separate study
that is in progress.
The technical aspects of these procedures were
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particularly demanding. The incisions were planned
to use the best venous conduit available and to avoid
excessive flap undermining or skin bridges. The use
of techniques other than the in situ technique
allowed lateral or subfascial tunneling. Arm vein
conduit was avoided so that future dialysis access was
not compromised. Minimal arterial dissection and
tourniquet control was used routinely. All the inci-
sions were closed with interrupted nylon sutures
that were left in place for 3 to 4 weeks. The techni-
cal adequacy of the bypass grafts was confirmed with
intraoperative color duplex scanning or with angiog-
raphy in all cases. The follow-up care was meticulous
and included graft surveillance with color duplex
scanning at 3-month intervals. Postoperative edema
was treated with graduated support hosiery.
Statistical analysis included univariate and multi-
variate risk analyses for the outcomes of mortality
and amputation rates. The Student t test was used
for continuous outcomes, and c 2 analysis was used
for categorical outcomes, with statistically significant
results being entered into a Cox proportional haz-
ards regression model. Bypass graft patency rates,
limb salvage rates, and survival rates were estimated
with life-table analysis.12,13
RESULTS
Thirty-four patients underwent 41 pedal bypass
grafting procedures during the study period—7
patients required bilateral procedures. This repre-
sented 35% of all bypass grafts in patients with ESRD
(n = 117) and 6% of all infrainguinal reconstructions
(n = 647) that were performed during the study 
period. Twenty-nine patients were undergoing
hemodialysis, and 3 were undergoing peritoneal dial-
ysis. Two patients had functioning renal transplants.
Twenty patients (59%) were men, and 14 (41%) were
women. The average age in the study was 64 years
(range, 39 to 85 years). The indication for bypass
grafting was limb salvage in all the cases. Twenty-six
limbs (63%) were seen with digital gangrene, 8 (20%)
with ulceration, and 7 (17%) with gangrene that
involved the heel. Almost half of the patients at the
time of presentation had undergone either amputa-
tion (n = 6; 18%) or revascularization (n = 9; 26%) of
the contralateral extremity.
All the bypass grafts were fashioned from auto-
genous conduits and had their distal anastomosis at
the level of the ankle or on the foot. Thirty-six
bypass grafts (88%) went to the dorsalis pedis artery,
13 (32%) from the femoral artery, and 23 (56%)
from the popliteal artery. Five bypass grafts (12%)
were performed to the posterior tibial artery at the
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ankle, 3 (7%) from the femoral artery, and 2 (5%)
from the popliteal artery. The in situ saphenous vein
served as a conduit in 17 limbs (42%), the nonre-
versed transposed saphenous vein in 14 (35%), and
the reversed saphenous vein in 7 (18%). Alternative
or spliced veins were used in 2 cases (5%), both with
lesser saphenous veins.
The preoperative risk factors and their correla-
tions with the outcomes of amputation or death are
shown in Table I. The application of univariate
analysis showed that smoking and heel gangrene
were statistically correlated with early amputation (P
< .05) and smoking with early death (P = .05). Both
of these remained statistically significant indepen-
dent predictors of poor outcomes when examined
by multivariate analysis (P < .05).
Although there was no correlation between
bypass graft length and outcome, the patients with
the in situ bypass graft configuration were more like-
ly to survive than were the patients with other bypass
graft conduits (P = .01). Age, gender, and a cardiac
ejection fraction of less than 35% showed no statisti-
cal correlations with amputation or death.
Noninvasive vascular laboratory data were com-
pared before and after the pedal bypass grafting pro-
cedure. The ABI values were measured in 16
patients (39%) before bypass grafting and in 34
(83%) after bypass grafting, and the TP was obtained
in 18 patients (44%) before the procedure and 20
(49%) after the procedure. The ABI values and the
TPs were significantly improved after bypass grafting
(P < .05; Table II).
The patient follow-up periods ranged from 1 to 
84 months, with an average of 13.5 months. Three
weeks after surgery, a single death (2.4%) occurred
from malignant cardiac arrhythmia during dialysis.
Although 21 patients (62%) remained ambulatory,
only 11 (32%) walked without assistance after bypass
grafting. At the time of the study closure, 16 limbs
(39%) had been amputated—3 (19%) above-knee and
13 (81%) below-knee. During the same study period,
67 amputations were performed on patients undergo-
ing dialysis in our institution—20 (30%) above-knee
and 47 (70%) below-knee. Seven amputations (44%)
were performed with a patent bypass graft, and 2
(13%) were performed after the ligation of bypass
grafts for rupture caused by infection. All the amputa-
tions with patent bypass grafts resulted from an inabil-
ity to heal wounds and a continued sepsis, rather than
bypass graft failure. The remaining 7 amputations were
necessitated by bypass graft thrombosis. Ten amputa-
tions (63%) occurred within 3 months of surgery.
After bypass grafting, the patients required an
average of 2.7 local foot procedures (range, 0 to 9)
in an attempt to attain an intact limb. Ten limbs
(24%) needed toe amputations and 5 (12%) needed
transmetatarsal amputations. Two limbs (5%) under-
went free tissue transfer. Eight of the 9 patients (89%)
who required more than 4 foot procedures either lost
their limb or died within the first 3 months. Four of
the 7 limbs (57%) that were seen with heel gangrene
needed amputation, and 4 of 6 patients (67%)—1
with bilateral heel gangrene—were dead by 6 months
(P = .04). In fact, all the patients with heel gangrene
had early limb loss or died or both.
Life table analysis was used to estimate the
cumulative bypass graft patency rates, the limb sal-
vage rates, and the patient survival rates. Two-year
statistics were chosen because of the small study
group and the limited life span of patients with
ESRD. The cumulative assisted primary patency rate
was 62% at 1 and 2 years. In the small number of
bypass grafts (5) that were available for late follow-
up examination, there were no further occlusions or
amputations after 2 years. The limb salvage rates
were 56% and 50% at 1 and 2 years, respectively. The
patient survival rates were similarly limited at 64% at
1 year and at 52% at 2 years. Fig 1 illustrates the
remarkably similar life-table analysis for patency
rates, limb salvage rates, and survival rates.
DISCUSSION
The last decade has seen impressive advances in
infrainguinal bypass grafts for limb salvage. This has
been accompanied by a similar progress in RRT. The
United States Renal Data System now reports over
200,000 patients in this country undergoing RRT.
Diabetes remains the most common cause of ESRD,
with nephropathy developing in 35% of the patients
and ESRD developing in one third of those patients.
During the period between 1980 and 1994, the sur-
Table I. Risk factor correlations in patients with
end-stage renal disease who require pedal bypass
grafting
No. of Outcome 
Risk factor patients (%) (amputation/mortality)
Diabetes 31 (91%) NS
Hypertension 32 (94%) NS
Coronary artery 28 (82%) NS
disease
Ejection fraction <35% 11 (34%) NS
Smoking 10 (29%) P < .05
Heel gangrene 7 (17%) P < .05
NS, Not significant.
Their results are somewhat superior to the results of
the present study, but the bypass type was not charac-
terized and the population was small. Their recom-
mendation for primary amputation in the case of large
ulcers has been contested, but the present study sup-
ports this, especially in the case of hind-foot gangrene.
In a recent study on amputation after lower extremity
bypass grafting, Reifsnyder et al19 showed a high prob-
ability of amputation with patent bypass grafts when
heel gangrene was the presenting lesion.
The report from New York by Harrington et al4
suggests that similar criteria for operation be used
for patients with ESRD and for patients who are not
undergoing dialysis. In that study, however,
femoropopliteal bypass grafting with polytetrafluo-
roethylene graft was the most frequent procedure
and only 16 bypass grafting procedures were per-
formed to the tibial level. Whittemore et al6 report-
ed acceptable results in patients with chronic renal
insufficiency, but, in the subgroup undergoing dial-
ysis, the primary patency rate was only 22% at 2 years
and no patient survived 3 years. Other reports have
correlated failure with extensive gangrene, with the
history of a previous failed bypass graft, and with the
failure to augment ABI after bypass grafting.8-10 The
present study clearly documents that hemodynamic
failure was not a cause for limb loss; both the ABI
value and the TP rose significantly after bypass graft-
ing (P < .05). These discrepant findings underline a
persistent difficulty in assessing appropriate candi-
dates for aggressive limb salvage attempts.
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vival rate for patients undergoing dialysis has slowly
but steadily improved. The 1-year survival rate has
increased from 70.1% to 77.7%, and the 2-year survival
rate from 51.8% to 61.9%. The 5-year survival rate
remains poor at 29.4%.11 This has resulted in a larger
population at risk for the accelerated atherosclerosis
that is peculiar to this group. Hyperhomocystinemia
has recently been proposed as a mechanism for this
variant of atherosclerosis.14,15 Patients with ESRD
exhibit primarily distal occlusive disease that is charac-
terized by heavy calcification, which makes bypass
grafting technically challenging. In addition, the
patient with uremia shows poor wound healing and an
unusual susceptibility to infection.16
As distal arterial imaging and surgical techniques
have improved, bypass grafting to the inframalleolar
arteries has become feasible, if not routine.17,18
Pomposelli et al1 report the largest series in the lit-
erature, and pedal bypass grafting now constitutes
approximately 25% of their lower extremity bypass
graft procedures. In their series of 384 pedal bypass
graft procedures, only 21 (5%) were performed on
patients who were undergoing RRT. They report an
impressive patency rate of 68% at 5 years with 87%
limb salvage but do not evaluate the results in the
ESRD group separately. The more sobering results
of the present study reflect its restriction to patients
with ESRD.
Previous reports of revascularization in patients
with ESRD have been more comparable with the
present series. The 2-year outcomes have been pre-
sented because of the well-documented mortality
rates in this high-risk group. The analysis of the data
from 6 reports2-4,7,8,10 provides information on 273
patients with ESRD who required revascularization.
The average patency rate at 1 year was 75% and at 2
years was 65%. The limb salvage rates were 78% and
69% at 1 and 2 years, respectively. Nevertheless, these
series included multiple levels and types of revascu-
larizations. One series included 13 pedal bypass
grafts,10 which represents the largest experience with
this subgroup up to this time. The present study
shows comparable bypass graft patency rates (62% at
2 years), with slightly lower limb salvage rates (50%
at 2 years). This is not unexpected because this group
with the most severe distal disease required incisions
and anastamoses in close proximity to open wounds
that acted as portals for infection.
Edwards et al2 reported the first critical review of
patients with ESRD who required revascularization for
critical ischemia. As in this study, that limb salvage rate
lagged behind the bypass graft patency rate, which
reflects ongoing necrosis despite a patent bypass graft.
Fig 1. Life-table analysis for assisted primary patency
rates, limb salvage rates, and survival rates for patients with
end-stage renal disease who are undergoing pedal bypass
grafting.
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Although bypass graft patency rates and limb sal-
vage rates have been acceptable even in this extreme
group of patients, the patient selection criteria for
bypass grafting remain a problem. The challenge is to
identify which patients will go on to early limb loss or
death and to avoid these trying hospitalizations with
the judicious use of primary amputation. In cases of
stable small ulcers or limited dry gangrene, simple
observation may be preferable to intervention and its
resultant cascade of problems.7 In our series, the
smokers were significantly more likely to go on to limb
loss or death (P = .05), but it is hard to withhold treat-
ment on this basis. On the other hand, cardiac status,
even severely diminished ejection fraction, was not a
predictor of early amputation or death. Heel necrosis
was a strong negative predictor for survival, which sug-
gests that these severely debilitated patients were
rapidly approaching the end of life. Once an aggressive
approach has been adopted, it is difficult to backtrack,
but patients who require multiple foot procedures for
the control of large lesions do not fare well and, again,
earlier amputation would seem advisable.
CONCLUSION
Bypass grafting to the pedal artery in patients with
ESRD is feasible and can be expected to result in
modest success in patients who are carefully selected.
The patency rates and limb salvage rates are compara-
ble with other bypass graft series for patients with
ESRD. Most amputations and deaths occur in the
first 3 months, after which the results stabilize. The
only consistent preoperative predictor for failure is
heel gangrene, and primary amputation should be
offered to this high-risk group. The challenge remains
to better identify which patients are more or less like-
ly to benefit from this aggressive limb salvage policy.
We thank Janine Janosky, PhD, for her assistance in
the statistical interpretation of the data.
REFERENCES
1. Pomposelli FB Jr, Marcaccio EJ, Gibbons GW, et al. Dorsalis
pedis arterial bypass: durable limb salvage for foot ischemia in
patients with diabetes mellitus. J Vasc Surg 1995;21:375-84.
2. Edwards JM, Taylor LM, Porter JM. Limb salvage in end-
stage renal disease (ESRD). Arch Surg 1988;123:1164-8.
3. Chang BB, Paty PS, Shah DM, et al. Results of infrainguinal
bypass for limb salvage in patients with end-stage renal dis-
ease. Surgery 1990;108:742-7.
4. Harrington EB, Harrington ME, Schanzer H, et al. End-
stage renal disease—Is infrainguinal limb revascularization
justified? J Vasc Surg 1990;12:691-6.
5. Sanchez LA, Goldsmith J, Rivers SP, et al. Limb salvage
surgery in end stage renal disease: is it worthwhile? J
Cardiovasc Surg 1992;33:344-8.
6. Whittemore AD, Donaldson MC, Mannick JA. Infrainguinal
reconstruction for patients with chronic renal insufficiency. J
Vasc Surg 1993;17:32-41.
7. Lumsden AB, Besman A, Jaffe M, et al. Infrainguinal revas-
cularization in end-stage renal disease. Ann Vasc Surg 1994;
8:107-12.
8. Baele HR, Piotrowski JJ, Yuhas J, et al. Infrainguinal bypass
in patients with end-stage renal disease. Surgery 1995;117:
319-24.
9. Simsir SA, Cabellon A, Kohlman-Trigoboff D, et al. Factors
influencing limb salvage and survival after amputation and
revascularization in patients with end-stage renal disease. Am
J Surg 1995;170:113-7.
10. Johnson BL, Glickman MH, Bandyk DF, et al. Failure of foot
salvage in patients with end-stage renal disease after surgical
revascularization. J Vasc Surg 1995;22:280-6.
11. United States Renal Data System 1997 Annual Data Report.
Bethesda (MD): National Institutes of Health, National
Institute of Diabetes and Digestive and Kidney Diseases;
1997 Ch V, 1-33.
12. Kaplan EL, Meier P. Nonparametric estimation from incom-
plete observations. Journal of American Statistics Association
1972;53:457-81.
13. Underwood CJ, Faragher EB, Charlesworth D. The uses and
abuses of life-table methods in vascular surgery. Br J Surg
1984;71:495-8.
14. Robinson K, Gupta A, Dennis V, et al. Hyperhomocysteinemia
confers an independent increased risk of atherosclerosis in end-
stage renal disease and is closely linked to plasma folate and
pyridoxine concentrations. Circulation 1996;94:2743-8.
15. Welch GN, Loscalzo J. Mechanisms of disease: homocysteine
and atherothrombosis. N Engl J Med 1998;338:1042-50.
16. Drutz DJ. Altered cell-mediated immunity and its relation-
ship to infection susceptibility in patients with uremia.
Dialysis and Transplantation 1979;8:320-3.
17. Andros G, Harris RW, Salles-Cunha SX, et al. Bypass grafts to
the ankle and foot. J Vasc Surg 1988;7:785-94.
18. Klamer TW, Lambert GE Jr, Richardson JD, et al. Utility of
inframalleolar arterial bypass grafting. J Vasc Surg 1990;11:
164-70.
19. Reifsnyder T, Grossman JP, Leers SA. Limb loss after lower
extremity bypass. Am J Surg 1997;174:149-51.
Submitted May 7, 1998; accepted Sep 18, 1998.
Table II. Noninvasive data before and after pedal bypass grafting
Parameter Before bypass grafting (range) After bypass grafting (range)
Ankle brachial index 0.48 (0 to 0.95) n = 16 1.05 (0.73 to 1.47) n = 34
Toe pressure (mm Hg) 18 (0 to 78) n = 18 86 (24 to 164) n = 20
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Dr Herbert Dardik (Englewood, NJ). The authors
are to be commended for bringing to our attention a par-
ticularly troubling subset of patients faced with limb loss.
Their data, which deal with inframalleolar revasculariza-
tion, are unique and should prove useful to us in our
practices. Our antennae should go up when the terms
“realistic” and “sobering” are used. As a good paper
should, this one certainly gives us information that makes
us think twice and perhaps, for some of our patients, we
ought to reconsider treatment options. In their thought-
ful and detailed analysis, the authors have shown that the
half-lives at 2 years for graft patency, limb salvage, and
patient survival are all in the neighborhood of 50%, a lit-
tle bit better for the graft patency itself. The additional
reality to their numbers includes the extra procedures
dealing with foot lesions and the high number of ampu-
tations, almost half of which were required despite graft
patency. The take-home message is: Think primary ampu-
tation if a patient with end-stage renal disease with heel
gangrene is being considered for pedal revascularization.
I have a few questions for the authors.
1. Is heel gangrene a problem because dorsalis pedis
revascularization is somewhat remote and in a dif-
ferent geographic location within the foot circula-
tion itself? And as a corollary, were any of your pos-
terior tibial revascularizations performed in the
presence of heel gangrene?
2. Would you consider free-flap transfers as an option
for the patient with heel gangrene?
3. Was there a possibility in your series for more proxi-
mal reconstructions to the tibial or peroneal arteries?
Many surgeons perform dorsalis pedis reconstruc-
tions preferentially even with adequate crural arteries.
I believe that patients with obligatory dorsalis pedis
reconstructions are in a different category than those
where options also exist for reconstructions to crural
vessels. By definition, this latter group of patients has
a greater runoff circulation than those with obligato-
ry reconstructions to a dorsalis pedis artery and, at
least intuitively, they should do better.
4. Finally, how did you deal technically with the prob-
lem of calciphylaxis, which, as you indicated, is a
definite characteristic of these patients? We routine-
ly use the tourniquet for lower level revasculariza-
tion, and in our last 45 patients, there was only a
single hemostatic failure. Obviously, this is a low
frequency of failure (less than 2%), but this did
occur in a patient with severe calcification of the
arteries who was undergoing dialysis. I would be
interested as to how you manage this problem.
I thank the Society for the opportunity to discuss this
paper.
Dr Steven A. Leers. Thank you for your comments
and questions, Dr Dardik. We share the same concerns as
you. When patients present with extensive heel gangrene,
we seriously talk to them before we undertake any revas-
cularization and in some patients, we actually have refused
bypass grafting.
In answer to your question about the regional blood
supply to the foot—does dorsalis pedis flow not get to the
heel in the patients with heel gangrene—I think that is a
realistic question. We have had a couple of bypass grafts to
the posterior tibial artery in patients with heel gangrene,
and the outcome still has been poor. I do not believe that
lack of regional flow is a problem.
Regarding free flaps, 1 of the patients, a young dia-
betic on dialysis who had a popliteal-to-pedal bypass graft,
underwent a free flap, did well, and then presented about
3 months later with pus underneath the flap involving the
ankle joint. Although that is a consideration, as you know,
it is a major surgical undertaking and we have restricted
free tissue transfer to the fairly young and active patients.
It has not helped.
Do we use proximal targets? In general, we look for a
proximal target if it provides direct flow to the foot.
Certainly, a proximal anterior tibial or posterior tibial is
preferable, as you have suggested, particularly because we
can keep incisions off of the foot. And we are concerned
about these incisions on the foot. As you know, in at least
2 of our bypass grafts, the pedal anastomosis ruptured and
there is not much you can do about that.
Early on in our experience, we performed a bypass
grafting to peroneal arteries that did not directly fill either
the posterior tibial or the dorsalis pedis. Those patients
went on to limb loss. So, if we have just a peroneal runoff,
we perform bypass grafting to that if we feel that the ter-
minal peroneal branches feed a good quality dorsalis pedis
or posterior tibial. But in a fair number of these patients,
the peroneal artery just peters out at the ankle. If that is
the case, we prefer to go to the dorsalis pedis.
We, too, use tourniquets on all of these patients. On
occasion the patients still bleed when we put on the
tourniquet, and we then increase the pressure or we add a
second tourniquet. We always have managed to be able to
sew the vessels. One of the thornier problems is the total-
ly calcified vessel that will not accept a needle. We have
had to deal with these on a couple of occasions, and it is
frustrating, but I cannot say that those patients did any
worse than any of the others.
Dr Benjamin B. Chang (Albany, NY). I have a couple
of comments. Unlike most patients without renal disease,
whose feet will heal from basically anything you do when
you fix their circulation, for people with renal disease, half
the story is done when you perform the bypass grafting
and the other half is actually what you do with the foot
afterwards.
For forefoot gangrene, you did not specify or stratify
exactly what you did in terms of foot procedures. We
found the use of, for instance, modified Chopart’s proce-
dures or free flaps mandatory in many of these cases for
DISCUSSION
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limb salvage. In the case of patients with heel gangrene,
which, I agree, is probably the most onerous group of
these patients, we have done well with 3 general things—
debridement, partial resection of the calcaneus, and simply
patience, followed by skin grafting or free flaps. I was
wondering if you have any way of elaborating on your
general plan for either forefoot or heel ischemia and if you
have any comments on such a plan as I am suggesting?
And I was also wondering if you would actually consider
doing more free flaps on some of your patients?
Thanks.
Dr Leers. Thank you, Dr Chang. In answer to your
question, we have evolved over the last couple of years in
how we handle the forefoot. Now, we will, for a single-
digit or 2-digit gangrene, obviously do a single-digit or a
double-digit amputation. But if we find that failing, we
move early to either a transmetatarsal amputation or, as
you have described, a Lisfranc’s or a Chopart’s amputa-
tion. We have a low threshold, if it looks like we are begin-
ning down that road, to do a fairly short full-foot trans-
metatarsal amputation, again hoping that we are going to
have proximal enough skin margins that look good.
Having said that, some of our most depressing losses were
patients with pulsatile flow at the time of debridement that
simply would not heal, even after a free flap.
Regarding the heel, we have generally been patient, as
you have. We had 1 patient in our series who had a free
flap—the rest were treated conservatively with either pro-
tection or debridement and skin grafting. We have not had
the luck that you have, I am sorry to say.
We think about free-flap reconstruction in these
patients, but these results are sobering. The free flap, as
you know, is a major undertaking, and these are elderly,
debilitated patients. My feeling is that these patients with
heel gangrene are trying to tell us something. I think they
are at the beginning of the end of their life. When we see
those patients now, we try to keep our hands off.
Robert W. Hobson II (Newark, NJ). I enjoyed your
paper. And I agree with you and Dr Dardik (and I am sure
everyone in this room) that the heel gangrene group is a
particularly vexing group with which to deal. The message
I am getting from your paper, though, is that under no cir-
cumstances would you do a dorsalis pedis bypass graft pro-
cedure in that patient. The question I have, from your
angiograms that you have done before and during surgery,
is whether there is any pattern of flow in the foot that would
suggest an exception to universal primary amputation?
Thank you.
Dr Leers. That is a good question, and I think the
answer is no. Our intraoperative angiograms sometimes
show that there is another vessel in the foot that is not
shown on the preoperative angiogram. I cannot say, how-
ever, that poor dorsalis pedis bypass grafts with poor
runoff have done worse. Some of our long-term survivals
had isolated dorsalis pedis grafts with minimal branching
and no pedal arch. In general, we have not found that our
intraoperative angiograms gave us any more information
that would have been helpful.
In terms of whether we offer patients with heel gan-
grene any procedure, we are obviously careful about that.
If we feel the patient is in a significantly debilitated state,
we simply will not offer the bypass grafting. The 50-year-
old ambulatory diabetic patient on dialysis is different, and
we are more aggressive in that case, especially with an
intact pedal arch.
Gary G. Nicholas (Allentown, Pa). I have 1 question
for you.
We looked at our series of patients with end-stage
renal disease and distal bypass grafts and found similar
results in mortality and patency rates and really came to
recommending a conservative course to our patient popu-
lation. But the most discouraging part of this group, as
compared with most of the patients in whom we perform
distal bypass grafting, was their low rate of ambulation
after a distal bypass graft. We found that this was really dis-
mally low and questioned how many of these patients real-
ly benefit in a functional way. Do you have any data on
ambulatory status, either assisted or free ambulation, after
your distal bypass grafts?
Dr Leers. We did look at that. Although the ambulation
status was reasonably satisfactory in the patients with sal-
vaged limbs, obviously that ambulation was limited. These
are generally debilitated, elderly patients, who walk with a
walker to the bathroom, to the kitchen, and that is about it.
We, too, have adopted a conservative approach in
patients who present with fairly stable minor degrees of
gangrene. I think they do as well, and these are people
who are only going to live a couple of years.
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APPENDIX. LIFE TABLES FOR BYPASS GRAFT PATENCY (A), LIMB SALVAGE (B), AND
PATIENT SURVIVAL (C)
A.
No. of No. of No. of No. of Interval Interval Overall Standard
patients occluded patients lost patients probability probability probability error of the
Interval entering study grafts to follow-up at risk of occlusion of patency of patency mean (%)
0 to 3 41 10 6 38 0.263 0.737 100 0
6 Mar 25 2 4 23 0.087 0.913 0.737 1.51
9 Jun 19 0 5 16.5 0 1 0.673 2.02
12 Sep 14 1 3 12.5 0.08 0.92 0.673 2.75
15 Dec 10 0 3 8.5 0 1 0.619 3.82
15 to 18 7 0 3 5.5 0 1 0.619 5.46
18 to 21 4 0 0 4 0 1 0.619 9.55
21 to 24 4 0 0 4 0 1 0.619 9.55
B.
No. of No. of patients No. of No. of Interval Interval Overall Standard
patients undergoing patients lost patients probability probability of probability of error of the
Interval entering study amputation to follow-up at risk of amputation limb salvage limb salvage mean (%)
0 to 3 41 10 5 38.5 0.26 0.74 100 0
6 Mar 26 4 4 24 0.17 0.83 0.74 1.45
9 Jun 18 1 6 15 0.07 0.93 0.61 2.11
12 Sep 11 0 1 10.5 0 1 0.56 3.38
15 Dec 10 1 2 9 0.11 0.89 0.56 3.71
15 to 18 7 0 3 5.5 0 1 0.5 5.05
18 to 21 4 0 0 4 0 1 0.5 8.84
21 to 24 4 0 0 4 0 1 0.5 8.84
C.
No. of No. of No. of No. of Interval Interval Overall Standard
patients patients patients lost patients probability probability probability error of the
Interval entering study who died to follow-up at risk of death of death of survival mean (%)
0 to 3 34 6 1 33.5 0.18 0.82 100 0
6 Mar 27 3 3 25.5 0.12 0.88 0.82 1.29
9 Jun 21 2 4 19 0.11 0.89 0.72 1.81
12 Sep 15 0 3 13.5 0 1 0.64 2.56
15 Dec 12 2 2 11 0.18 0.82 0.64 3.2
15 to 18 8 0 2 7 0 1 0.52 4.5
18 to 21 6 0 1 5.5 0 1 0.52 6
21 to 24 5 0 0 5 0 1 0.52 7.2
